Izquierdo I - Search Results

1

Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study.

Martínez-Cócera C, De Molina M, Martí-Guadaño E, Pola J, Conde J, Borja J, Pérez I, Arnaiz E, Izquierdo I; Spanish Rupatadine Rhinitis Study Group. Martínez-Cócera C, et al. Among authors: izquierdo i. J Investig Allergol Clin Immunol. 2005;15(1):22-9. J Investig Allergol Clin Immunol. 2005. PMID: 15864879 Clinical Trial.

2

A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptor-specific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis.

Saint-Martin F, Dumur JP, Pérez I, Izquierdo I; French Rupatadine-Rhinitis Study Group. Saint-Martin F, et al. Among authors: izquierdo i. J Investig Allergol Clin Immunol. 2004;14(1):34-40. J Investig Allergol Clin Immunol. 2004. PMID: 15160440 Clinical Trial.

3

Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study.

Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E. Dubertret L, et al. Among authors: izquierdo i. Eur J Dermatol. 2007 May-Jun;17(3):223-8. doi: 10.1684/ejd.2007.0153. Epub 2007 May 4. Eur J Dermatol. 2007. PMID: 17478385 Clinical Trial.

4

Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study.

Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E; Rupatadine Urticaria Study Group. Gimenez-Arnau A, et al. Among authors: izquierdo i. Allergy. 2007 May;62(5):539-46. doi: 10.1111/j.1398-9995.2007.01330.x. Allergy. 2007. PMID: 17441794 Clinical Trial.

5

Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber.

Stuebner P, Horak F, Zieglmayer R, Arnáiz E, Leuratti C, Pérez I, Izquierdo I. Stuebner P, et al. Among authors: izquierdo i. Ann Allergy Asthma Immunol. 2006 Jan;96(1):37-44. doi: 10.1016/S1081-1206(10)61038-1. Ann Allergy Asthma Immunol. 2006. PMID: 16440531 Clinical Trial.

6

Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.

Fraj J, Valero A, Vives R, Pérez I, Borja J, Izquierdo I, Picado C. Fraj J, et al. Among authors: izquierdo i. Allergy. 2008 Jan;63(1):112-5. doi: 10.1111/j.1398-9995.2007.01473.x. Allergy. 2008. PMID: 18053020 Clinical Trial.

7

A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis.

Fantin S, Maspero J, Bisbal C, Agache I, Donado E, Borja J, Mola O, Izquierdo I; international Rupatadine study group. Fantin S, et al. Among authors: izquierdo i. Allergy. 2008 Jul;63(7):924-31. doi: 10.1111/j.1398-9995.2008.01668.x. Allergy. 2008. PMID: 18588560 Clinical Trial.

8

Reference values for facilitating the interpretation of the ESPRINT-15 questionnaire (Spanish version).

Valero A, Baró E, Sastre J, Navarro-Pulido AM, Izquierdo I, Martí-Guadaño E, Ferrer M, Dávila I, del Cuvillo A, Colas C, Antepara I, Alonso J, Mullol J. Valero A, et al. Among authors: izquierdo i. J Investig Allergol Clin Immunol. 2009;19(5):396-403. J Investig Allergol Clin Immunol. 2009. PMID: 19862940 Free article.

9

Safety of rupatadine administered over a period of 1 year in the treatment of persistent allergic rhinitis: a multicentre, open-label study in Spain.

Valero A, de la Torre F, Castillo JA, Rivas P, del Cuvillo A, Antépara I, Borja J, Donado E, Molà O, Izquierdo I. Valero A, et al. Among authors: izquierdo i. Drug Saf. 2009;32(1):33-42. doi: 10.2165/00002018-200932010-00003. Drug Saf. 2009. PMID: 19132803 Clinical Trial.

10

No cardiac effects of therapeutic and supratherapeutic doses of rupatadine: results from a 'thorough QT/QTc study' performed according to ICH guidelines.

Donado E, Izquierdo I, Pérez I, García O, Antonijoan RM, Gich I, Solans A, Peña J, Morganroth J, Barbanoj MJ. Donado E, et al. Among authors: izquierdo i. Br J Clin Pharmacol. 2010 Apr;69(4):401-10. doi: 10.1111/j.1365-2125.2009.03599.x. Br J Clin Pharmacol. 2010. PMID: 20406224 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

635 results

Search Page